» Articles » PMID: 10393896

A Dimeric Mutant of Human Pancreatic Ribonuclease with Selective Cytotoxicity Toward Malignant Cells

Overview
Specialty Science
Date 1999 Jul 8
PMID 10393896
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Monomeric human pancreatic RNase, devoid of any biological activity other than its RNA degrading ability, was engineered into a dimeric protein with a cytotoxic action on mouse and human tumor cells, but lacking any appreciable toxicity on mouse and human normal cells. This dimeric variant of human pancreas RNase selectively sensitizes to apoptotic death cells derived from a human thyroid tumor. Because of its selectivity for tumor cells, and because of its human origin, this protein represents a potentially very attractive, novel tool for anticancer therapy.

Citing Articles

Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.

Gotte G, Menegazzi M Front Immunol. 2019; 10:2626.

PMID: 31849926 PMC: 6901985. DOI: 10.3389/fimmu.2019.02626.


Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases.

Mironova N, Vlassov V Front Pharmacol. 2019; 10:1019.

PMID: 31572192 PMC: 6753386. DOI: 10.3389/fphar.2019.01019.


Small Molecule-Induced Domain Swapping as a Mechanism for Controlling Protein Function and Assembly.

Karchin J, Ha J, Namitz K, Cosgrove M, Loh S Sci Rep. 2017; 7:44388.

PMID: 28287617 PMC: 5347425. DOI: 10.1038/srep44388.


A Ribonuclease Isolated from Wild Ganoderma Lucidum Suppressed Autophagy and Triggered Apoptosis in Colorectal Cancer Cells.

Dan X, Liu W, Wong J, Ng T Front Pharmacol. 2016; 7:217.

PMID: 27504094 PMC: 4958627. DOI: 10.3389/fphar.2016.00217.


A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.

Vert A, Castro J, Ribo M, Benito A, Vilanova M Oncotarget. 2016; 7(14):18309-24.

PMID: 26918450 PMC: 4951290. DOI: 10.18632/oncotarget.7579.


References
1.
Kunkel T . Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985; 82(2):488-92. PMC: 397064. DOI: 10.1073/pnas.82.2.488. View

2.
Adinolfi B, Cafaro V, DAlessio G, Di Donato A . Full antitumor action of recombinant seminal ribonuclease depends on the removal of its N-terminal methionine. Biochem Biophys Res Commun. 1995; 213(2):525-32. DOI: 10.1006/bbrc.1995.2163. View

3.
Parente A, Merrifield B, Geraci G, DAlessio G . Molecular basis of superreactivity of cysteine residues 31 and 32 of seminal ribonuclease. Biochemistry. 1985; 24(5):1098-104. DOI: 10.1021/bi00326a005. View

4.
Ciglic M, Jackson P, Raillard S, Haugg M, Jermann T, Opitz J . Origin of dimeric structure in the ribonuclease superfamily. Biochemistry. 1998; 37(12):4008-22. DOI: 10.1021/bi972203e. View

5.
Weickmann J, ELSON M, Glitz D . Purification and characterization of human pancreatic ribonuclease. Biochemistry. 1981; 20(5):1272-8. DOI: 10.1021/bi00508a035. View